Zhengye Biotechnology Holding (ZYBT) Retained Earnings (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Retained Earnings for 3 consecutive years, with -$3.1 million the latest figure, recorded in Q4 2025.

• Quarterly Retained Earnings fell 145.5% year-over-year to -$3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.1 million (down 145.5% YoY) and the FY2025 annual result came in at -$3.1 million, down 146.98% from the prior year.
• Retained Earnings fell to -$3.1 million in Q4 2025 per ZYBT's latest filing, from $3.7 million in the prior quarter.
• Over the last five years, Retained Earnings for ZYBT reached as high as $6.7 million in Q4 2024 and fell as low as -$3.1 million in Q4 2025.
• A 3-year average of $3.2 million and a median of $4.5 million in 2025 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings increased 25.75% — and 2025, when it slumped 145.5%.
• Year by year, Retained Earnings stood at $5.3 million in 2023, then gained by 25.75% to $6.7 million in 2024, then sank by 145.5% to -$3.1 million in 2025.
• According to Business Quant data, Retained Earnings over the past three periods registered -$3.1 million, $3.7 million, and $6.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.